Glass House Brands (GLAS) Return on Invested Capital (2021 - 2026)

Glass House Brands' (GLAS) quarterly Return on Invested Capital came in at 0.22% in Q1 2026, down 119.93% on a QoQ basis from 1.09% in Q4 2025.

Glass House Brands (GLAS) Return on Invested Capital (2021 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 3 years of Return on Invested Capital data on file, last reported at 0.22% in Q1 2026.

On a quarterly basis, Return on Invested Capital changed N/A year-over-year to 0.22% in Q1 2026; TTM through Mar 2026 was 0.22%, a N/A change from a year earlier, with the FY2025 full-year figure at 0.13%, changed N/A from the prior year.
Return on Invested Capital for Q1 2026 stood at 0.22%, down from 1.09% in the prior quarter.
Over the last five years, Return on Invested Capital for GLAS reached as high as 1.09% in Q4 2025 and fell as low as 0.22% in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Haleon	89.28 Bn	87.42 Bn	-	-
2	Teva Pharmaceutical Industries	35.97 Bn	32.23 Bn	1.97 Bn	0.01%
3	Zoetis	32.42 Bn	30.48 Bn	1.62 Bn	0.01%
4	Takeda Pharmaceutical	27.48 Bn	23.42 Bn	4.39 Bn	0.00%
5	United Therapeutics	22.89 Bn	20.73 Bn	648.10 Mn	-
6	RedHill Biopharma	22.11 Bn	22.11 Bn	-	-
7	Viatris	20.44 Bn	18.64 Bn	1.16 Bn	0.00%
8	Neurocrine Biosciences	17.76 Bn	16.44 Bn	800.70 Mn	-
9	Elanco Animal Health	12.62 Bn	12.19 Bn	785.00 Mn	0.03%
10	Glass House Brands	873.84 Mn	845.91 Mn	10.02 Mn	-0.22%

Download Data